REFERENCES
1. Zerboni G, Signoretti M, Crippa S, Falconi M, Arcidiacono PG, Capurso G. Systematic review and meta-analysis: prevalence of incidentally detected pancreatic cystic lesions in asymptomatic individuals. Pancreatology 2019;19:2-9.
2. Rawla P, Sunkara T, Gaduputi V. Epidemiology of pancreatic cancer: global trends, etiology and risk factors. World J Oncol 2019;10:10-27.
3. Munigala S, Gelrud A, Agarwal B. Risk of pancreatic cancer in patients with pancreatic cyst. Gastrointest Endosc 2016;84:81-6.
4. Schweber AB, Agarunov E, Brooks C, Hur C, Gonda TA. Prevalence, incidence, and risk of progression of asymptomatic pancreatic cysts in large sample real-world data. Pancreas 2021;50:1287-92.
5. Anand N, Sampath K, Wu BU. Cyst features and risk of malignancy in intraductal papillary mucinous neoplasms of the pancreas: a meta-analysis. Clin Gastroenterol Hepatol 2013;11:913-21; quiz e59.
6. Okasha HH, Awad A, El-Meligui A, et al. Cystic pancreatic lesions, the endless dilemma. World J Gastroenterol 2021;27:2664-80.
7. Miller FH, Lopes Vendrami C, Recht HS, et al. Pancreatic cystic lesions and malignancy: assessment, guidelines, and the field defect. Radiographics 2022;42:87-105.
8. Buerke B, Domagk D, Heindel W, Wessling J. Diagnostic and radiological management of cystic pancreatic lesions: important features for radiologists. Clin Radiol 2012;67:727-37.
9. Scholten L, van Huijgevoort NCM, van Hooft JE, Besselink MG, Del Chiaro M. Pancreatic cystic neoplasms: different types, different management, new guidelines. Visc Med 2018;34:173-7.
10. Xu MM, Yin S, Siddiqui AA, et al. Comparison of the diagnostic accuracy of three current guidelines for the evaluation of asymptomatic pancreatic cystic neoplasms. Medicine 2017;96:e7900.
11. Miura T, Igarashi Y, Okano N, Miki K, Okubo Y. Endoscopic diagnosis of intraductal papillary-mucinous neoplasm of the pancreas by means of peroral pancreatoscopy using a small-diameter videoscope and narrow-band imaging. Dig Endosc 2010;22:119-23.
12. Cooper CL, O’Toole SA, Kench JG. Classification, morphology and molecular pathology of premalignant lesions of the pancreas. Pathology 2013;45:286-304.
13. Mukai H, Yasuda K, Nakajima M. Differential diagnosis of mucin-producing tumors of the pancreas by intraductal ultrasonography and peroral pancreatoscopy. Endoscopy 1998;30 Suppl 1:A99-102.
14. Study Group on Cystic Tumours of the Pancreas. European evidence-based guidelines on pancreatic cystic neoplasms. Gut 2018;67:789-804.
15. Hisada Y, Nagata N, Imbe K, et al. Natural history of intraductal papillary mucinous neoplasm and non-neoplastic cyst: long-term imaging follow-up study. J Hepatobiliary Pancreat Sci 2017;24:401-8.
16. Lawson R, Savides T, Kwong W, Hunt G, Giap A. Risk of pancreatic cancer in patients with cystic lesions of the pancreas based upon EUS morphology. In Presented at 78th Annual Scientific Meeting of The American College of Gastroenterology; 11-16 October 2013. San Diego, CA, USA. Available from: https://journals.lww.com/ajg/Fulltext/2013/10001/Risk_of_Pancreatic_Cancer_in_Patients_with_Cystic.305.aspx [Last accessed on 15 Apr 2023].
17. Lee SH, Park JK, Woo SM, et al. Natural history of branch-duct type intraductal papillary mucinous neoplasms of the pancreas. Korean J Gastroenterol 2007;49:24-30. Available from: https://europepmc.org/article/med/18167430 [Last accessed on 15 Apr 2023]
18. Gonzalez I, Tang RS, Munroe CA, et al. Natural history of pancreatic cysts < 6 cm with benign EUS appearance without surgical resection. In Presented at Digestive Disease Week; 19-22 May 2012; San Diego, CA, USA. Available from: https://doi.org/10.1016/j.gie.2012.04.370 [Last accessed on 15 Apr 2023].
19. Nougaret S, Reinhold C, Chong J, et al. Incidental pancreatic cysts: natural history and diagnostic accuracy of a limited serial pancreatic cyst MRI protocol. Eur Radiol 2014;24:1020-9.
20. Lekkerkerker SJ, Fockens P, Besselink M, Rauws E, Van Hooft JE. 105 malignant progression during long-term follow-up of pancreatic cysts: how often do we change teatment strategy? Gastrointestinal Endoscopy 2015;81:AB115.
21. Broughton J, Lipschitz J, Cantor M, Moffatt D, Abdoh A, McKay A. Determining the natural history of pancreatic cystic neoplasms: a Manitoban cohort study. HPB 2016;18:383-8.
22. Pak LM, D’Angelica MI, DeMatteo RP, et al. Natural history of patients followed radiographically with mucinous cysts of the pancreas. J Gastrointest Surg 2017;21:1599-605.
23. Ohno E, Hirooka Y, Kawashima H, et al. Natural history of pancreatic cystic lesions: a multicenter prospective observational study for evaluating the risk of pancreatic cancer. J Gastroenterol Hepatol 2018;33:320-8.
24. Lee BS, Nguyen AK, Tekeste TF, et al. Long-term follow-up of branch-duct intraductal papillary mucinous neoplasms with No change in first 5 years of diagnosis. Pancreatology 2021;21:144-54.
25. Farrell JJ. Prevalence, diagnosis and management of pancreatic cystic neoplasms: current status and future directions. Gut Liver 2015;9:571-89.
26. Zhang XP, Yu ZX, Zhao YP, Dai MH. Current perspectives on pancreatic serous cystic neoplasms: diagnosis, management and beyond. World J Gastrointest Surg 2016;8:202-11.
27. Mohamed E, Jackson R, Halloran CM, Ghaneh P. Role of radiological imaging in the diagnosis and characterization of pancreatic cystic lesions: a systematic review. Pancreas 2018;47:1055-64.
28. Jabłońska B, Szmigiel P, Mrowiec S. Pancreatic intraductal papillary mucinous neoplasms: current diagnosis and management. World J Gastrointest Oncol 2021;13:1880-95.
29. Gavini H, Lee JH. Endoscopic ultrasound-guided endotherapy. J Clin Gastroenterol 2015;49:185-93.
30. Kawada N, Uehara H, Katayama K, et al. Diagnostic clues and subsequent examinations that detected small pancreatic cancer. Hepatogastroenterology 2012;59:1665-9.
31. Serrani M, Lisotti A, Caletti G, Fusaroli P. Role of contrast harmonic-endoscopic ultrasound in pancreatic cystic lesions. Endosc Ultrasound 2017;6:25-30.
32. Muthusamy VR, Chandrasekhara V, Acosta RD, et al. The role of endoscopy in the diagnosis and treatment of cystic pancreatic neoplasms. Gastrointest Endosc 2016;84:1-9.
33. Boot C. A review of pancreatic cyst fluid analysis in the differential diagnosis of pancreatic cyst lesions. Ann Clin Biochem 2014;51:151-66.
34. Kadiyala V, Lee LS. Endosonography in the diagnosis and management of pancreatic cysts. World J Gastrointest Endosc 2015;7:213-23.
35. Thosani N, Thosani S, Qiao W, Fleming JB, Bhutani MS, Guha S. Role of EUS-FNA-based cytology in the diagnosis of mucinous pancreatic cystic lesions: a systematic review and meta-analysis. Dig Dis Sci 2010;55:2756-66.
36. Thornton GD, McPhail MJ, Nayagam S, Hewitt MJ, Vlavianos P, Monahan KJ. Endoscopic ultrasound guided fine needle aspiration for the diagnosis of pancreatic cystic neoplasms: a meta-analysis. Pancreatology 2013;13:48-57.
37. Soyer OM, Baran B, Ormeci AC, et al. Role of biochemistry and cytological analysis of cyst fluid for the differential diagnosis of pancreatic cysts: a retrospective cohort study. Medicine 2017;96:e5513.
38. Brugge WR, Lewandrowski K, Lee-Lewandrowski E, et al. Diagnosis of pancreatic cystic neoplasms: a report of the cooperative pancreatic cyst study. Gastroenterology 2004;126:1330-6.
39. Cao S, Hu Y, Gao X, Liao Q, Zhao Y. Serum carbohydrate antigen 19-9 in differential diagnosis of benign and malignant pancreatic cystic neoplasms: a meta-analysis. PLoS One 2016;11:e0166406.
41. Khan I, Baig M, Bandepalle T, Puli SR. Utility of cyst fluid carcinoembryonic antigen in differentiating mucinous and non-mucinous pancreatic cysts: an updated meta-analysis. Dig Dis Sci 2022;67:4541-8.
42. Smith ZL, Satyavada S, Simons-Linares R, et al. Intracystic glucose and carcinoembryonic antigen in differentiating histologically confirmed pancreatic mucinous neoplastic cysts. Am J Gastroenterol 2022;117:478-85.
43. Faias S, Prazeres S, Cunha M, et al. Chromogranin a and NSE in cystic pancreatic neuroendocrine tumors. Clin Res Hepatol Gastroenterol 2021;45:101601.
44. Levy A, Popovici T, Bories PN. Tumor markers in pancreatic cystic fluids for diagnosis of malignant cysts. Int J Biol Markers 2017;32:e291-6.
45. Hollingsworth MA, Strawhecker JM, Caffrey TC, Mack DR. Expression of MUC1, MUC2, MUC3 and MUC4 mucin mRNAs in human pancreatic and intestinal tumor cell lines. Int J Cancer 1994;57:198-203.
46. Maker AV, Carrara S, Jamieson NB, et al. Cyst fluid biomarkers for intraductal papillary mucinous neoplasms of the pancreas: a critical review from the international expert meeting on pancreatic branch-duct-intraductal papillary mucinous neoplasms. J Am Coll Surg 2015;220:243-53.
47. Lee LS, Banks PA, Bellizzi AM, et al. Inflammatory protein profiling of pancreatic cyst fluid using EUS-FNA in tandem with cytokine microarray differentiates between branch duct IPMN and inflammatory cysts. J Immunol Methods 2012;382:142-9.
48. Maker AV, Katabi N, Qin LX, et al. Cyst fluid interleukin-1beta (IL1beta) levels predict the risk of carcinoma in intraductal papillary mucinous neoplasms of the pancreas. Clin Cancer Res 2011;17:1502-8.
49. Lee LS, Bellizzi AM, Banks PA, et al. Differentiating branch duct and mixed IPMN in endoscopically collected pancreatic cyst fluid via cytokine analysis. Gastroenterol Res Pract 2012;2012:247309.
50. Keane MG, Huggett MT, Chapman MH, et al. Diagnosis of pancreaticobiliary malignancy by detection of minichromosome maintenance protein 5 in biliary brush cytology. Br J Cancer 2017;116:349-55.
51. Matthaei H, Wylie D, Lloyd MB, et al. miRNA biomarkers in cyst fluid augment the diagnosis and management of pancreatic cysts. Clin Cancer Res 2012;18:4713-24.
52. Farrell JJ, Toste P, Wu N, et al. Endoscopically acquired pancreatic cyst fluid microRNA 21 and 221 are associated with invasive cancer. Am J Gastroenterol 2013;108:1352-9.
53. Ryu JK, Matthaei H, Dal Molin M, et al. Elevated microRNA miR-21 levels in pancreatic cyst fluid are predictive of mucinous precursor lesions of ductal adenocarcinoma. Pancreatology 2011;11:343-50.
54. Lee LS, Szafranska-Schwarzbach AE, Wylie D, et al. Investigating MicroRNA expression profiles in pancreatic cystic neoplasms. Clin Transl Gastroenterol 2014;5:e47.
55. Pontious C, Kaul S, Hong M, et al. Cathepsin E expression and activity: role in the detection and treatment of pancreatic cancer. Pancreatology 2019;19:951-6.
56. Singhi AD, Nikiforova MN, Fasanella KE, et al. Preoperative GNAS and KRAS testing in the diagnosis of pancreatic mucinous cysts. Clin Cancer Res 2014;20:4381-9.
57. Wu J, Matthaei H, Maitra A, et al. Recurrent GNAS mutations define an unexpected pathway for pancreatic cyst development. Sci Transl Med 2011;3:92ra66.
58. Singhi AD, McGrath K, Brand RE, et al. Preoperative next-generation sequencing of pancreatic cyst fluid is highly accurate in cyst classification and detection of advanced neoplasia. Gut 2018;67:2131-41.
59. Facciorusso A, Del Prete V, Antonino M, Buccino VR, Wani S. Diagnostic yield of EUS-guided through-the-needle biopsy in pancreatic cysts: a meta-analysis. Gastrointest Endosc 2020;92:1-8.e3.
60. Yang D, Samarasena JB, Jamil LH, et al. Endoscopic ultrasound-guided through-the-needle microforceps biopsy in the evaluation of pancreatic cystic lesions: a multicenter study. Endosc Int Open 2018;6:E1423-30.
61. Guo J, Bhutani MS, Giovannini M, et al. Can endoscopic ultrasound-guided needle-based confocal laser endomicroscopy replace fine-needle aspiration for pancreatic and mediastinal diseases? Endosc Ultrasound 2017;6:376-81.
62. Kohoutova D, Zar S, Repak R, Vlavianos P, Bures J. Pancreatic cysts: diagnostic role of EUS-guided microforceps biopsy and confocal laser endomicroscopy. Gastroenterol Res Pract 2019;2019:3431048.
63. Facciorusso A, Buccino VR, Sacco R. Needle-based confocal laser endomicroscopy in pancreatic cysts: a meta-analysis. Eur J Gastroenterol Hepatol 2020;32:1084-90.
64. de Jong DM, Stassen PMC, Groot Koerkamp B, et al. The role of pancreatoscopy in the diagnostic work-up of intraductal papillary mucinous neoplasms: a systematic review and meta-analysis. Endoscopy 2023;55:25-35.
65. Hara T, Yamaguchi T, Ishihara T, et al. Diagnosis and patient management of intraductal papillary-mucinous tumor of the pancreas by using peroral pancreatoscopy and intraductal ultrasonography. Gastroenterology 2002;122:34-43.
66. Clores MJ, Thosani A, Buscaglia JM. Multidisciplinary diagnostic and therapeutic approaches to pancreatic cystic lesions. J Multidiscip Healthc 2014;7:81-91.
67. Kurita Y, Kuwahara T, Hara K, et al. Diagnostic ability of artificial intelligence using deep learning analysis of cyst fluid in differentiating malignant from benign pancreatic cystic lesions. Sci Rep 2019;9:6893.
68. Kuwahara T, Hara K, Mizuno N, et al. Usefulness of deep learning analysis for the diagnosis of malignancy in intraductal papillary mucinous neoplasms of the pancreas. Clin Transl Gastroenterol 2019;10:1-8.
69. Springer S, Masica DL, Dal Molin M, et al. A multimodality test to guide the management of patients with a pancreatic cyst. Sci Transl Med 2019:11.
70. Oh HC, Seo DW, Lee TY, et al. New treatment for cystic tumors of the pancreas: EUS-guided ethanol lavage with paclitaxel injection. Gastrointest Endosc 2008;67:636-42.
